INTRODUCTION
Neutrophils, the largest subset of granulocytes, are the first line of defense against various infections caused by bacteria, fungi, and parasites. Neutrophils traffic into infected tissues and clear pathogens while secreting proinflammatory cytokines that may cause tissue damage (Nathan, 2006) . Because of their short life span, hematopoietic stem cells continuously produce granulocytes at a basal or emergent stage, requiring a strict regulation of granulopoiesis (Christopher and Link, 2007) .
Granulocyte-colony stimulating factor receptor (G-CSFR) is the master regulator of granulopoiesis because both G-CSF and G-CSFR genetically ablated mice develop severe neutropenia (Lieschke et al., 1994; Liu et al., 1996) . Binding of G-CSF to G-CSFR activates a signaling cascade, including phosphorylation of signal transducer and activator of transcription (Stat3), a key regulator of basal and emergent granulopoiesis (Avalos, 1996) . Similar with its function as a proproliferative oncogene in tumor (Yu et al., 2009 ), Stat3 also promotes mitogenic signaling to facilitate neutrophil production in response to G-CSF (Avalos, 1996) , and hyperactive Stat3 induces enhanced granulopoiesis (Croker et al., 2004) . Consistent with the finding that Stat3 antagonizes Stat1 and Stat5 activation in T helper cell differentiation and tumor environment (Welte et al., 2003) G-SCF only weakly activates Stat1 and Stat5 in Stat3-proficient models (Avalos, 1996; Chakraborty et al., 1996; Tian et al., 1994) . However, once the antagonizing function of Stat3 is lost in Stat3 conditional genetically ablated mice, hyperactive Stat1 compensates for Stat3 and becomes an alternative G-CSFR downstream pathway, resulting in neutrophilia (Lee et al., 2002) . Taken together, Stat3 expression and activation need to be properly controlled for normal granulopoiesis. In addition, loss of b 2 -integrin or leukocyte-endothelial (LE)-selectin induces neutrophilia because of elevated basal amounts of G-CSF and IL-17 (Forlow et al., 2001; Stark et al., 2005) , suggesting a noncellular autonomous feedback mechanism, while loss of CXC-chemokine receptor-4 (CXCR-4) affects granulopoiesis in a cellular autonomous fashion (Eash et al., 2009) . The possibility that inhibitory coreceptors may also regulate G-CSFR-dependent granulopoiesis has not been investigated.
In this respect, CEACAM1 is a likely candidate based on its high expression on neutrophils and its known role as an inhibitory coreceptor in the immune system (Gray-Owen and Blumberg, 2006) . The CEACAM1 molecule consists of cytoplasmic, transmembrane, and extracellular domains. The extracellular domains comprise a membrane distal IgV-like N-domain, followed by a variable number of IgC-like domains. The N-domain mediates homophilic ligation with other CEACAM1 molecules or heterophilic ligation with other CEA family members (Gray-Owen and Blumberg, 2006) . Both human and murine CEACAM1 transcripts undergo alternative splicing, generating 11 human and four murine isoforms (Gray-Owen and Blumberg, 2006) . The CEACAM1 long form has two ITIMs in its cytoplasmic domain, which, upon phosphorylation, recruit Src homology domain-containing protein-tyrosine phosphatases SHP-1 and -2, which, in turn, suppress signal transduction of associated receptors by dephosphorylation of their downstream effectors (Gray-Owen and Blumberg, 2006) . In activated T cells, recruitment of SHP-1 by CEACAM1 downregulates TCR signaling by targeting Zap-7 (Chen et al., 2008) and IL-2R signaling (Chen and Shively, 2004) . Overexpression of CEACAM1 long forms in T cells prevents inflammatory bowel disease (IBD) in a murine colitis model (Nagaishi et al., 2006) . In germinal B cells, antiIgM induces CEACAM1 phosphorylation, SHP-1 recruitment, and subsequent suppression of PI3-K signaling, leading to potentiated activation-induced cell death (AICD) (Lobo et al., 2009) . Although these studies demonstrate how CEACAM1 regulates immune effector cell function, the possibility that CEACAM1 may regulate immune cell development has not been addressed. Although CEACAM1 plays a role in activation and apoptosis of neutrophils (Singer et al., 2002 (Singer et al., , 2005 , its role in granulopoiesis and neutrophil-dependent innate immune response in infectious models has not been investigated.
Here, we use retroviral transduction and bone marrow reconstitution to reintroduce CEACAM1, ITIM-mutated CEACAM1 into Ceacam1 À/À bone marrow (BM), or to normalize p-Stat3 amounts in Ceacam1 À/À BM and study the effects on granulopoiesis and innate immune response. Our results demonstrate that CEACAM1 regulates myeloid development by functioning as a coinhibitory receptor of G-CSFR through ITIM and SHP-1, leading to downregulation of downstream Stat3 activation, and the absence of CEACAM1 results in elevated G-CSFR-Stat3 signaling and neutrophilia, which, in turn, adversely affects the innate immune response to pathogenic bacteria.
RESULTS

CEACAM1 Is a Granulocytic Lineage Differentiation Marker
Neutrophils, monocytes, and macrophages from wild-type (WT) mice expressed high amounts of CEACAM1, with neutrophil expression found at a significantly higher amount compared to monocytes and macrophages ( Figure 1A ). In addition, peripheral blood neutrophils (PBNs) that are more mature than bone marrow neutrophils (BMNs) expressed a slightly higher amount of CEACAM1 on the cell surface than BMNs. We also examined the expression of CEACAM1 on lineage-negative bone marrow (Lin À BM) cells by immunoblot ( Figure 1B ) and flow-cytometric analysis ( Figure 1C ). Although these progenitor cells expressed a relatively lower amount of CEACAM1 compared to the mature innate immune cells, granulocyte-monocyte progenitors (GMPs) that specifically give rise to granulocytes and monocytes expressed higher amounts of CEACAM1 than common myeloid precursors (CMPs) and megakaryocyte-erythrocyte precursors (MEPs) ( Figure 1C ). These results indicate that from the early progenitor stage to the final effector stage, cell-surface CEACAM1 amounts correlate with granulocytic lineage differentiation. We also compared the long and short forms of CEACAM1 by quantitative real-time PCR using CEACAM1 long form and short form specific primers, showing that neutrophils and Lin À BM cells expressed both the long and short forms of CEACAM1 at the mRNA level ( Figure 1D ) with a general preference for the long form (in neutrophils, the Long:Short [L:S] ratio was about 1.76; in Lin À BM cells, the L:S ratio was about 1.41). Figure 2A ). This dysregulated granulopoiesis could be explained by an accumulation of neutrophils with a slower turnover rate or an augmented neutrophil production from myeloid progenitor cells. To test the first possibility, we utilized the in vitro spontaneous apoptosis assay (Johnnidis et al., 2008) and found that Ceacam1 À/À neutrophils underwent normal or slightly faster apoptosis than WT ones (Figures S1A-S1B available online). To test the second possibility, we assessed neutrophil progenitor cell proliferation in the methylcellulose colony formation assay. G-CSF-treated Ceacam1 À/À BM produced 2-fold more neutrophil colonies than WT ( Figure 2B ). Ceacam1 À/À BM had 1.6 times the number of GMPs than WT ( Figure 2C ). When the proliferative capacity of the GMPs was measured by bromodeoxyuridine (BrdU) incorporation, there was a higher ratio of BrdU + GMPs in Ceacam1 À/À mice than the WT ( Figure 2D ). Since there was no obvious difference in BrdU incorporation of WT or Ceacam1 À/À neutrophils (data not shown), the observed neutrophilia in Ceacam1 À/À mice does not result from proliferation of neutrophils. In G-CSF-induced emergent granulopoiesis (Croker et al., 2004; Roberts et al., 1997) in WT mice, bone marrow neutrophil and peripheral blood counts were 21 3 10 6 and 15 3 10 5 /ml, respectively, while in G-CSF-treated Ceacam1 À/À mice, enhanced granulopoiesis was observed (BMN 95 3 10 6 , PBN 112 3 10 5 /ml) ( Figure 2E ).
These results suggest that CEACAM1 negatively regulates G-CSF-mediated basal (homeostatic) and emergent granulopoiesis and that genetically ablating CEACAM1 leads to neutrophilia because of neutrophil progenitor cell hyperproliferation.
Ceacam1
-/-BM Cells Act Autonomously, and CEACAM1 Regulation of Progenitor Cells Is Granulocytic Lineage Specific b 2 -integrin or LE-selectin genetically ablated mice develop neutrophilia in a nonautonomous feedback mechanism (Forlow et al., 2001; Stark et al., 2005) . To study if this mechanism applies to CEACAM1, reverse BM reconstitution was performed in which we transplanted WT BM cells into lethally irradiated Ceacam1 Figure S1C ). To test if CEACAM1's regulation on progenitor cells is granulocytic lineage specific, we carried out a BM competition assay in which equivalent amounts of BM cells from Ceacam1 À/À C57BL/6 (CD45.2) and congenic WT C57BL/6 (CD45.1) mice were coinjected into lethally irradiated WT C57BL/6 recipients. We found that 81% of the BMNs expressed CD45.2, while for BM B cells, the ratio of CD45.1 + : CD45.2 + was close to 1:1 ( Figure S1D ), a result consistent with our observation that Ceacam1 À/À mice did not have abnormal numbers of BM or spleen B or T cells (data not shown). We also found that there were more CD45.2 + (Ceacam1
BM derived) GMP populations than CD45.1 + , confirming CEACAM1 regulates early granulopoiesis autonomously (data not shown). In methylcellulose assays, Ceacam1
À/À and WT BM gave rise to similar numbers of erythrocyte, megakaryocyte, or macrophage colonies ( Figure S2E ). We conclude that the effect of CEACAM1 on progenitor cells is granulocytic lineage specific.
CEACAM1 Downregulates G-CSFR Stat3 Signaling
Since CEACAM1 acts as a coinhibitory receptor for many receptors (Gray-Owen and Blumberg, 2006) and G-CSFR is the central mediator of granulopoiesis (Avalos, 1996) , we hypothesized that CEACAM1 negatively regulates G-CSFR signaling. Treatment of WT Lin À BM cells with G-CSF induced significant tyrosine phosphorylation of CEACAM1, while IP of CEACAM1 co-IPed G-CSFR in the G-CSFtreated Lin À BM cells, indicating that CEACAM1 is physically associated with G-CSFR after G-CSF treatment ( Figure 3A ). Accordingly, the amount of p-Stat3 in Ceacam1 À/À Lin À BM cells was 2-fold higher than in the WT Lin À BM cells after G-CSF treatment ( Figure 3B ), as well as increased amounts of p-Stat3 in Ceacam1 À/À GMPs as measured by intracellular staining (Figure 3C) . Analysis of other G-CSFR downstream molecules exhibited no difference of p-Stat1, p-Stat5, p-Akt, or p-Erk1/2 between WT and Ceacam1 À/À Lin À BM cells after G-CSF treatment ( Figure S2 ). The proproliferative Stat3 target genes, CyclinD1 and C-Myc, (Yu et al., 2009) , were induced at a higher amount in Lin À BM cells after G-CSF treatment ( Figure 3D ). Also, sorted Ceacam1 À/À GMPs transcribed more CyclinD1 and C-Myc mRNA after G-CSF treatment ( Figure 3E ). Thus, elevated Stat3 activation is primarily responsible for neutrophilia in Ceacam1 À/À mice.
CEACAM1 Inhibits G-CSFR-Stat3 Signaling and Granulopoiesis through ITIM Recruitment of SHP-1
The CEACAM1 long form contains two ITIMs and is the isoform that mediates an SHP-1-dependent suppressive signal upon ITIM phosphorylation (Gray-Owen and Blumberg, 2006) . Although WT Lin À BM cells expressed both long and short isoform transcripts of CEACAM1, we assumed that the inhibitory effect of CEACAM1 on granulopoiesis and G-CSFR signaling is ITIM-SHP-1 dependent. To test this hypothesis, we reintroduced CEACAM1 long form (CEACAM1-2L, CEACAM1-4L), short form (CEACAM1-2S, CEACAM1-4S), and ITIM tyrosine mutated long form (CEACAM1-2Lm and CEACAM1-4Lm) into Ceacam1
BM stem cells and transplanted them into lethally irradiated Ceacam1 À/À recipients ( Figures S3A-S3C ). Two months after reconstitution, we found that CEACAM1 long forms, but not the short forms, restored normal neutrophil populations ( Figures  4A and 4B ), normal GMP populations (data not shown), and normal p-Stat3 amounts ( Figure 4C ). Moreover, mutating the tyrosines in the ITIMs prevented this restoration ( Figures 4A-4C ).
We carried out IP analysis to determine if the physical interaction between CEACAM1 and G-CSFR is ITIM-SHP-1 dependent. Interestingly, G-CSF induced tyrosine phosphorylation of both the CEACAM1 long form and short form (the murine CEACAM1 short forms have a tyrosine site in their cytoplasmic domains) ( Figure 4D ). As expected, there was no tyrosine phosphorylation of CEACAM1 in the Lin À BM cells isolated from Ceacam1
mice reintroduced with CEACAM1-2Lm, CEACAM1-4Lm, or empty vector ( Figure 4D ). Consistent with our hypothesis, G-CSFR was pulled down by anti-CEACAM1 upon G-CSF treatment only in the Lin À BM cell lysates isolated from Ceacam1
mice reintroduced with CEACAM1 long form ( Figure 4D ). We also demonstrated that CEACAM1 associates with SHP-1 upon G-CSF treatment in WT Lin À BM cells ( Figure 3A) or Lin À BM cells isolated from Ceacam1 À/À mice receiving CEACAM1-2L or CEACAM1-4L ( Figure 4D ), but not in Lin À BM cells recovered from Ceacam1 À/À mice receiving CEACAM1-2S, -4S, CEACM1-2Lm, -4Lm, or empty vector ( Figure 4D ). Thus, CEACAM1-SHP-1 association depends on the presence of the ITIMs in CEACAM1 long forms. In WT Lin À BM cells, SHP-1 also directly associated with G-CSFR as shown by IPs using anti-SHP-1 antibody ( Figure 4E ), leading to dephosphorylation of G-CSFR ( Figure 4F) . Notably, the SHP-1-G-CSFR association was abrogated in Ceacam1 À/À Lin À BM cells, revealing the indispensable role of CEACAM1 in recruiting SHP-1 to dephosphorylate G-SCFR. Lastly, the dependency of SHP-1 was confirmed by shRNA-mediated reduction of SHP-1 in WT mice, a treatment that caused augmented granulopoiesis associated with elevated G-CSFR-Stat3 signaling ( Figures S3D-S3G ). Therefore, we conclude that the CEACAM1 downregulation of the G-CSFRStat3 pathway depends on its ITIMs and recruitment of SHP-1.
Modulation of CEACAM1 Regulates Host Immune Response to LM Infection
To study the physiological impact of the enhanced granulopoiesis of Ceacam1 À/À mice, they were infected with Listeria Monocytogenes (LM), an infectious model in which neutrophils play an indispensable role in clearance during the early stages of infection (Eash et al., 2009; Nathan, 2006; Zhu et al., 2009) . Although enhanced bacteria clearance and prolonged survival of Ceacam1 À/À mice because of their neutrophilia was a likely outcome, it is also possible that loss of negative signaling by CEACAM1 and neutrophilia could lead to enhanced tissue damage and proinflammatory cytokine production. Indeed,
Ceacam1
À/À mice died dramatically faster than the WT mice;
in fact, almost all Ceacam1 À/À mice died within 7 days, while the WT mice had a 40% survival rate, even at day 12 ( Figure 5A ). Bacterial colonies in either the liver or spleen of Ceacam1 À/À mice 3 days postinfection were fewer compared with WT, showing that Ceacam1 À/À mice had improved bacterial clearance ( Figure 5B ). Therefore, the accelerated mortality was probably not because of failure of bacterial clearance in Ceacam1 À/À mice. Because it was also possible that lack of CEACAM1 affects neutrophil antibacterial functions, an in vitro bacterial killing assay was performed. In this assay, there was no significant difference between Ceacam1 À/À and WT neutrophils (Figure S4A) . Importantly, Ceacam1 À/À neutrophils also performed normally in actin-cytoskeleton rearrangement and migration assays ( Figures S4B-S4C) . Therefore, the improved bacterial clearance in Ceacam1 À/À mice was not because of abnormal migration or an abnormal bacterial killing function of Ceacam1 À/À neutrophils, but instead was because of increased neutrophil numbers in Ceacam1 À/À mice. However, the improved bacterial clearance in infected Ceacam1 À/À mice was accompanied by severe tissue damage and necrosis in the liver ( Figure 5C , quantified in Figure S4D ), likely caused by neutrophils. Indeed, significantly more neutrophils were recovered in infected Ceacam1 À/À livers than in the WT ones ( Figure 5D ). In addition, in LM infected Ceacam1 À/À mice, serum amounts of interleukin-1b (IL-1b), which was in the range associated with endotoxic shock (Greten et al., 2007) , and IL-6, keratinocytederived chemokine (KC), tumor necrosis factor-a (TNF-a) to a lesser degree, were higher compared to WT mice ( Figure 5E ). To further elucidate the cause of the elevated proinflammatory cytokine amounts in vivo, we analyzed whether CEACAM1 regulates cytokine production on a cellular basis. We examined neutrophils and macrophages, two major cellular sources of cytokine production during early days postinfection. When cells were stimulated in vitro with lipopolysaccharide (LPS), a toll-like receptor 4 (TLR4) ligand, or peptidoglycan (PGN), a TLR2 ligand, no significant difference in IL-1b, TNF-a, IL-6, and KC production was observed between WT and Ceacam1 À/À macrophages (Figure S5A) . Interestingly, Ceacam1 À/À neutrophils produced significantly more IL-1b (data not shown) but similar amounts of TNF-a, IL-6, and KC compared with WT neutrophils ( Figure S5B ). We conclude that while loss of CEACAM1 significantly affects neutrophil IL-1b production, there was no obvious effect on the production of other proinflammatory cytokines. Also, loss of CEACAM1 does not seem to affect macrophage production of proinflammatory cytokines. Based on the in vitro per cell based cytokine production profile, we inferred that the significantly higher serum amount of IL-1b in Ceacam1 À/À mice after LM infection was because of both elevated neutrophils and elevated IL-1b production capacity by individual Ceacam1 À/À neutrophils, while the moderately higher amounts of TNF-a, IL-6, and KC were likely because of increased neutrophil numbers only in Ceacam1 À/À mice.
Because neutrophilia in WT mice can be induced by G-CSF treatment (Croker et al., 2004; Roberts et al., 1997) , it was possible to examine the effects of increased neutrophils on cytokine production during LM infection. Indeed, in response to LM infection, the G-CSF-treated WT mice, which have comparable numbers of bone marrow and peripheral blood neutrophils as the Ceacam1 À/À mice without G-CSF treatment ( Figure 2E ), exhibited similar serum amounts of TNF-a, IL-6, and KC as Ceacam1 À/À mice ( Figure S5C ) and had a similar degree of liver damage ( Figure S5D , quantified in Figure S5E ), both of which were probably because of the abnormal number of neutrophils. However, their serum amount of IL-1b was dramatically lower than in Ceacam1 À/À mice, and the G-CSF treated WT mice showed better survival than Ceacam1 À/À mice ( Figure S5F ). Although the G-CSF treated WT mice had better bacterial clearance than untreated WT mice (data not shown), they showed poorer survival than the WT mice ( Figure S5F ), which could be because of the liver damage and elevated cytokine amounts as shown above, consistent with previous studies showing G-CSF treatment potentiated neutrophil-induced tissue damage and proinflammatory response (Croker et al., 2004; Roberts et al., 1997) . These results also indicated that the hypersensitivity of Ceacam1 À/À mice to LM infection was not solely because of the increased number of neutrophils, but was partially because of elevated proinflammatory cytokine amounts, especially IL-1b. Based on these findings, we conclude that the combination of severe liver damage and high proinflammatory cytokine amounts induced accelerated mortality of LM infected Ceacam1 À/À mice.
We also studied LM infected Ceacam1 À/À mice reconstituted with CEACAM1-2L, CEACAM1-4L CEACAM1-2S, CEACAM1-4S, CEACAM1-2Lm, CEACAM1-4Lm, or empty vector transduced Ceacam1 À/À BM cells. As expected, only CEACAM1-2L
or CEACAM1-4L rescued Ceacam1 À/À mice from hypersensitivity to LM infection ( Figure 6A ), with manifestation of greatly less liver damage ( Figure 6B , quantified in Figure S5G ) and lower serum cytokine amounts ( Figure 6C ). around 65%, which in turn, reduced p-Stat3, C-Myc, and CyclinD1 to the WT amounts after G-CSF stimulation ( Figure 7C ). In contrast, Stat1 and Stat5 remained weakly phosphorylated after reduction of total Stat3, confirming that Stat3 plays a dominant role downstream of G-CSFR. shRNA specificity was confirmed because shStat3 did not affect Stat1 or Stat5 amounts, and the shRNA control did not affect Stat protein amounts, ruling out the possibility of off-target effects. We then challenged these mice with LM and examined if normalized granulopoiesis could rescue the accelerated mortality of Ceacam1 À/À mice. Indeed, reduction of Stat3 partially rescued Ceacam1 À/À mice from hypersensitivity to LM infection as manifested by prolonged survival ( Figure 7D ) associated with less liver damage ( Figure 7E , quantified in Figure S6 ) and lower serum amounts of IL-6, TNF-a, and KC ( Figure 7F ). However, IL-1b remained high after reduction of total Stat3 by shRNA ( Figure 7F ), a finding that might explain their relatively poorer survival compared with WT mice, especially at early days postinfection.
DISCUSSION
Although CEACAM1 has been designated as a marker for neutrophil activation (Singer et al., 2002) and plays a role in neutrophil apoptosis (Singer et al., 2005) , a role for CEACAM1 in granuolopoiesis has not been studied. Here, we showed CEACAM1 is a granulocytic lineage differentiation marker, and Ceacam1 À/À mice had severe neutrophilia associated with hyperproliferation of Ceacam1 À/À neutrophil progenitor cells.
This finding, together with the general function of CEACAM1 as an inhibitory coreceptor in T cells (Gray-Owen and Blumberg, 2006) , led us to hypothesize that CEACAM1 may downregulate neutrophil production by acting as a coinhibitory receptor for G-CSFR, the master regulator of granulopoiesis (Liu et al., 1996; McLemore et al., 2001 ). This hypothesis was strengthened by the finding that in Lin À BM cells, G-CSFR was co-IPed with CEACAM1 when treated with G-CSF and that, under this condition, CEACAM1 was phosphorylated on its ITIMs and recruited SHP-1. The recruitment of SHP-1 downregulated G-CSFR signaling by decreasing the phosphorylation of G-CSFR, attenuating its downstream Stat3 activation and expression of mitogenic proteins Cyclin D1 and C-Myc, thereby controlling the proliferation of neutrophil progenitors. In the absence of CEACAM1 the negative feedback loop would be absent allowing neutrophil precursors to abnormally produce neutrophils. The inhibitory activity of CEACAM1 resides in the long isoforms that have two ITIMs that, when phosphorylated, recruit SHP-1 and -2 (Gray-Owen and Blumberg, 2006). Using retroviral vector transduced BM stem cell-based BM reconstitution assays, we demonstrated that the CEACAM1 long form was able to associate with G-CSFR and restore normal granulopoiesis and that mutation of the tyrosine residues in its ITIMs abrogated this restoration. Furthermore, we found that only the CEACAM1 long forms recruited the suppressive phosphatase SHP-1 and that SHP-1 antibodies were able to co-IP G-CSFR, leading to dephosphorylation of activated G-CSFR. We demonstrated the dependency of SHP-1 in regulating granulopoiesis by reduction of SHP-1 in WT mice by shRNA, a treatment that also leads to enhanced G-CSFR-Stat3 signaling and granulopoiesis, consistent with the previous observation that SHP-1 genetically ablated mice develop neutrophilia (Kruger et al., 2000) . Interestingly, G-CSF also induced tyrosine phosphorylation of the short isoform, although this isoform did not appear to associate with SHP-1 or regulate granulopoiesis. This intriguing result leaves open a role for the tyrosine residue in the murine short form of CEACAM1, although it is not present in the context of an ITIM. Notably, the human CEACAM1 short isoform has phenylalanine in place of tyrosine (Chen et al., 2007) . Thus, further studies are required to determine if the short isoform in murine CEACAM1 has any additional functions upon phosphorylation of its tyrosine residue.
Stat3, an oncogene in many tumors (Yu et al., 2009) , is the dominant Stat protein downstream of G-CSFR that positively regulates granulopoiesis (Avalos, 1996) . Stat3 also regulates proliferation of early progenitor cells of granulocytes (Zhang et al., 2010) and is subject to negative regulation by induction of SOCS3, a negative feedback loop of Stat signaling (Croker et al., 2004) . As expected, Socs3 À/À mice have hyper-p-Stat3 and enhanced granulopoiesis (Croker et al., 2004) . Similarly, our study of Ceacam1 À/À mice serves as another example in which loss of a negative regulator leads to hyper-p-Stat3 and hypergranulopoiesis. We examined this further by reducing Stat3 amounts in Ceacam1 À/À mice, which, in turn, normalized p-Stat3 amounts and completely restored normal granulopoiesis, confirming that hyper-p-Stat3 was the main factor with empty vector (emp), CC1-2L, CC1-4L, CC1-2S, CC1-4S, CC1-2Lm, and CC1-4Lm chimeras 24 hr after infection (mean ± SEM, n = 6 mice). p values were calculated between groups indicated by bars using one-way ANOVA.
responsible for neutrophilia in Ceacam1 À/À mice. Notably, Stat3 also antagonizes Stat1 and Stat5 activation (Lee et al., 2002) , which explains the weak activation of Stat1 and Stat5 in response to G-CSF in Stat3-proficient models (Avalos, 1996; Chakraborty et al., 1996; Tian et al., 1994) , while loss of Stat3 leads to alternative Stat1 hyperactivation, which, in turn, compensates for Stat3 and causes neutrophilia (Lee et al., 2002) . Although these investigators interpret these results as evidence that Stat3 is a negative regulator of granulopoiesis, we argue that loss of Stat3 abrogates its normal antagonistic function on Stat1 and Stat5 signaling. Similar antagonizing mechanisms occur in T helper (Th) cell differentiation and activation, where loss of Stat3 leads to augmented Stat1 activation and Th1 cell response (Welte et al., 2003) . In the case of the Stat3 conditional gene ablated studies (Lee et al., 2002) , evidence is provided that Stat3 is a negative regulator of Stat1 and Stat5 in granulopoiesis, but no evidence is provided that Stat3 is a negative regulator of granulopoiesis in wild-type or any other Stat3-proficient mice.
In this regard, Stat3-proficient Socs3 À/À mice (Croker et al., 2004) are not the equivalent situation to the Stat3 conditionally ablated mouse model, in which Stat1 mediated enhanced granulopoiesis (Lee et al., 2002) . Although the study of the Socs3 mice not only restored normal granulopoiesis but also normalized amounts of IL-1b, which correspondingly completely restored normal sensitivity to LM infection, demonstrating a critical checkpoint function for CEACAM1. However, it is worth noting that this checkpoint role is not limited to the G-CSFR-Stat3 pathway of granulopoiesis because while reduction of total Stat3 amounts in Ceacam1 À/À BM by shRNA completely restored normal granulopoiesis, serum IL-1b amounts remained high. We also examined whether loss of CEACAM1 affects cellular cytokine production by stimulating neutrophils and macrophages in vitro. Although no obvious difference in the cytokine production between WT and Ceacam1 À/À macrophages was observed, Ceacam1 À/À neutrophils produced slightly more IL-6 and significantly more IL-1b production (manuscript in preparation). Why loss of CEACAM1 preferably affects cytokine (IL-1b) production in neutrophils, but not in macrophages, remains an open question. Thus, our studies reveal CEACAM1 regulates both the quantitative and qualitative response of neutrophils to infection. In summary, CEACAM1 provides a critical negative feedback loop in the regulation of granulopoiesis and the corresponding innate immune response to infections, demonstrating the ''fine tuning'' of the innate immune system by a coinhibitory receptor. These insights should help us better understand the interactions between cell surface receptors orchestrating innate immune system development and may have clinical implications in treating infectious, autoinflammatory, and other innate immunityrelated diseases.
EXPERIMENTAL PROCEDURES Mice Strains
Ceacam1
À/À mice (C57B/6 background) were generated by Beauchemin and coworkers (Hemmila et al., 2004 ). C57BL/6 mice were from National Cancer
Institute and congenic CD45.1 C57B/6 mice were from The Jackson Laboratory. Seven-to twelve-week-old mice were used for all the experiments. To induce emergent granulopoiesis, G-CSF (2.5 ug/mouse, twice a day) was injected intraperitoneally (i.p.) into mice for 5 consecutive days.
Listeria Monocytogenes Infection and Colony Counting
Listeria Monocytogenes EGD (ATCC) were cultured overnight in DIFCO Listeria Enrichment Broth (BD Biosciences). Colony-forming units (CFUs) of LM were determined by plating serial dilutions of LM on BBL CHROMagar Listeria plates (BD Biosciences). 2.5 3 10 5 CFUs of LM were injected i.p. into mice.
Twenty-four hours later, peripheral blood was collected for cytokine amounts. Seventy-two hours later, livers and spleens were collected for histology and measurement of bacterial colony numbers 48 hr after plating.
Quantitative Real-Time PCR RNA extractions were performed with Trizol (Invitrogen). Reverse transcription was performed (QIAGEN) by real-time on a Bio-Rad IQ5. CEACAM1 isoforms, Cyclin D1, and C-Myc mRNA expression was normalized to HPRT. Primer sequences will be provided upon request.
Construction and Generation of Retroviral Vectors
CEACAM1-2L, 4L, 2S, or 4S cDNAs were cloned into retroviral vector (MSCV-EGFP). The ITIM mutations on CEACAM1-2L and -4L were generated using QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) The shRNA control vector, shStat3 vector (pGFP-V-RS) and Sh SHP-1 vector (pGFP-V-RS) were from Origene, and the target sequence of shStat3 vector is 5 0 -AGTTCCTGGCACCTTGGATTGAGAGTCAA-3 0 and the target sequence of shSHP-1 vector is 5 0 -TTGTGCGTGAGAGTCTCAGCCAACCTGGT-3 0 . All retroviral vectors were generated in Phoenix-Eco packaging cell line. For MSCV-EGFP-based vectors, viral titers of the supernatants from the stable virus-producing cells were determined in NIH 3T3 cells by flow cytometry. Primer sequences will be provided upon request.
Bone Marrow Reconstitution Assays
For reverse BM reconstitution assays, 7-week-old WT or Ceacam1 À/À mice were lethally irradiated with 1000 Gy, and 5 3 10 6 Ceacam1 À/À or WT BM cells were intravenously (i.v.) injected into the mice 8 hr after irradiation. Two months later, mice were sacrificed, and the ratio of cell lineages was assessed by flow cytometry. For BM competition assays, 7-week-old WT mice were coinjected with equivalent (1 3 10 6 ) Ceacam1 À/À (CD45.2) and congenic WT (CD45.1) BM cells after lethal irradiation.
Retroviral Transduction of Bone Marrow Stem Cells 5-Fluorouracil (5 mg/mouse) was injected i.p. into Ceacam1 À/À mice and BM stem cells were collected 5 days later and expanded in 10% FBS DMEM plus 20 ng/ml IL-3, 50 ng/ml IL-6, and SCF for 24 hr. Viral-based empty vector, CEACAM1-2L, -4L, -2S, -4S, -2Lm, and -4Lm transduced cells were sorted 48 to 72 hr later as GFP-positive cells. Viral-expressed shRNA control vector, shStat3 vector, and shSHP-1 vector were selected with puromycin (1 mg/ml) 7 days later. Collected cells were injected i.v into lethally irradiated Ceacam1 À/À recipients (1-5 3 10 5 cells/mouse) and phenotyped 2 months later.
Cell Sorting and Flow-Cytometric Analysis Lineage-negative BM (Lin À BM) cells were purified using antibody-magnetic bead depletion (Zhu et al., 2009) . Neutrophils (Ly-6G + CD11b + ) were labeled with FITC or PE-Cy5-conjugated anti-Ly-6G, APC-Cy7-conjugated antimouse CD11b. Monocytes (Ly-6C 
BrdU Incorporation Assays
BrdU was injected i.p into mice immediately followed by i.p. injection of LPS (25 mg/kg) or PBS. Six hours later, mice were sacrificed and GMPs were labeled as described above. BrdU was detected with APC-conjugated antibody from BD.
Methylcellulose Colony-Forming Assays 5 3 10 4 Lin À BM cells were cultured in Methylcellulose media supplemented with 20 ng/ml G-CSF, 20 ng/ml GM-CSF, 10 ng/ml SCF, 15 ng/ml EPO, and 10 ng/ml TPO (Sigma). After incubating at 37 C 5% CO 2 for 10 days, granulocyte colony numbers were counted according to corresponding morphologies.
Immunoblot, Immunoprecipitation, and ELISA Lin À myeloid progenitors (5 3 10 6 ) with or without G-CSF treatment were lysed using RIPA buffer (Sigma) supplemented with 4 mM Na 3 VO 4 , 50 mM NaF and 1 mM PMSF. Total cell extracts were examined by IP and immunoblot analysis using corresponding antibodies for specific proteins as previously described (Chen and Shively, 2004) . IL-1b, IL-6, KC, and TNF-a serum amounts were measured with ELISA kits according to manufacturers' manuals (Biolegend and R&D Systems).
SUPPLEMENTAL INFORMATION
Supplemental information includes six figures and Supplemental Experimental
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